Company / Interest Expense per Share
CytomX Therapeutics, Inc. Interest Expense per Share History
FY2016-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.05
FY2016
5-year range
-
FY2016-FY2016
Trend
-81.8%
vs FY2015
Sector context
#34 of 43
Health Care
What the data says
CytomX Therapeutics, Inc.'s interest expense per share of $0.05 is lower than 79% of companies in the Health Care sector (FY2016).
Based on SEC 10-K filings.
0.05 in FY2016.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 43This company $0.05 Sector average $18.61
▼
-99.8% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.68 (distress zone, below 1.8 threshold)
- Strong profit margin: 23.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $0.05 | -81.8% |
As of FY2016 · SEC 10-K · Updated Jul 2, 2026